Jason Katz

Jason Katz is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Director - Commercial Hematology Early Asset, Strategy, & Business Development at Bristol Myers Squibb since June 2017. Katz has demonstrated expertise in US forecasting and commercial analytics, with a focus on brand tactics and portfolio strategy across various roles, including Director of Hematology/Oncology Commercialization Analytics. Prior experience includes senior positions at Ipsos Healthcare, where market research was leveraged to provide insights for healthcare clients, and Zitter Health Insights, which involved consumer behavior analysis related to health insurance. Katz holds a Bachelor of Science in Biochemistry from Lehigh University and a Master of Engineering in Pharmaceutical Engineering from Rutgers University.